Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regintel
London, United Kingdomregintel.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Regintel is a regulatory intelligence company that provides an AI-powered platform designed for the life sciences, pharmaceutical, and medical device sectors. The company's technology centralizes and analyzes global regulatory data, offering real-time updates and impact assessments to help compliance teams navigate complex legal landscapes. By automating the monitoring of regulatory changes, Regintel enables companies to accelerate product development timelines and ensure continuous market access. The platform serves as a critical tool for regulatory affairs professionals seeking to streamline workflows and mitigate compliance risks.
- Industry
- Biomedical IT and Biomedical Data Platforms
Beyond the preview
Go deeper on Regintel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regintel.